![Ingelheim biomass plant inauguration cropped Ingelheim biomass plant inauguration cropped](/sites/default/files/2024-07/0O9A7814Bearb_cropped.jpg)
July 08, 2024
Boehringer Ingelheim produces its own green energy
![Boehringer Ingelheim advances SIRP immune-oncology program Pipettes with violet fluid](/sites/default/files/2024-07/PR_OSE2.jpg)
July 03, 2024
Boehringer Ingelheim advances SIRPα immuno-oncology program
![Phase 1 start for novel triple agonist obesity treatment Woman working in the lab on a laptop](/sites/default/files/2024-07/PR_Grupa.jpg)
July 01, 2024
Phase 1 start for novel triple agonist obesity treatment
![3-Lab-techs 3-Lab-techs](/sites/default/files/2024-06/3-Lab-techs-v2%20%281%29.png)
June 07, 2024
Survodutide shows breakthrough improvement in liver fibrosis
![Boehringer Ingelheim Economist Impact Boehringer Ingelheim Economist Impact](/sites/default/files/2024-05/Boehringer_Lifestyle_SocialLife_MeetingFriends-01_CMYK_018.png)
May 28, 2024
Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
![Man in the lab Man working in the lab](/sites/default/files/2024-05/PR_OSE.jpg)
May 22, 2024
Partnership for first-in-class cancer and CRM treatments
![Sheep with bell are looking at camera Sheep with bell are looking at camera](/sites/default/files/2024-05/Bultavo%20press%20release.jpg)
May 13, 2024
BULTAVO 3™ is a new vaccine that protects cattle and sheep against bluetongue virus serotype 3 (BTV-3)
![Hornbill Press Release Woman in the lab](/sites/default/files/2024-05/HornbillPR.jpg)
May 06, 2024
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia
![Veterinarian treats dog, chicken is being held in barn Veterinarian treats dog, chicken is being held in barn](/sites/default/files/2024-04/Veterinarian%20treats%20dog%2C%20chicken%20is%20being%20held%20in%20barn.jpg)
April 25, 2024
World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated
![boehringer_biopharmaceutical production_Biberach boehringer_biopharmaceutical production_Biberach](/sites/default/files/2024-04/boehringer_biopharmaceutical%20production_Biberach%20resized.jpg)
April 16, 2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
April 09, 2024
Boehringer Ingelheim Biopharmaceuticals China receives approval for supply of EU and US markets
![EMPA EMPA](/sites/default/files/2024-04/EMPA%20image.png)
April 06, 2024
Results announced from EMPACT-MI phase III trial
![Boehringer Workplace Lab Research Boehringer Workplace Lab Research](/sites/default/files/2024-03/Boehringer_Workplace_Lab_Research-01_RGB_003%20%281%29.jpg)
March 19, 2024
SPEVIGO® approved for expanded indications in China and the US
![Boehringer_Lifestyle_SocialLife_MeetingFriends Two persons talking](/sites/default/files/2024-03/Boehringer_Lifestyle_SocialLife_MeetingFriends-01_RGB_008.jpg)
March 11, 2024
New partnership to develop schizophrenia treatments
![MASH MASH](/sites/default/files/2024-03/MASH_klein_1_0.png)
February 26, 2024
Survodutide Phase II trial shows groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
![Girl with horse in front of a camera](/sites/default/files/2024-02/Sleip_Partnership_website.png)
February 19, 2024
The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.
![doctor pointing on spine](/sites/default/files/2024-02/CBmed.jpg)
February 08, 2024
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
![Employee in learning environment](/sites/default/files/2024-01/Untitled%20design%20%281%29.png)
January 18, 2024
Global Top Employer 2024 certification reflects Boehringer Ingelheim’s impactful people development
![Koropi groundbreaking](/sites/default/files/2024-01/Koropi%20groundbreaking.jpg)
January 11, 2024
Boehringer expands production site in Greece for new medicine
![Man with cat](/sites/default/files/2024-01/SENVELGO%20wins%20Best%20New%20Product%20for%20Companion%20Animals%20award%E2%80%8B.png)
January 10, 2024
SENVELGO® wins Best New Product for Companion Animals award
![Scientists/doctors looking on a tablet](/sites/default/files/2024-01/ADVANCE.jpg)
January 09, 2024
New study paves the way for liver cirrhosis treatments
![Discussion of doctors and caregivers](/sites/default/files/2024-01/JPM_summary.jpg)
January 09, 2024
Kicking off 2024 with five new R&D partnerships
![Kyowa](/sites/default/files/2024-01/Malin_Kyowa_1.jpg)
January 05, 2024
Boehringer Ingelheim licenses a new compound as part of its commitment to people living with fibro-inflammatory diseases from Kyowa Kirin
![Partnership 3T Bio Partnership 3T Bio](/sites/default/files/2024-01/Malin.png)
January 04, 2024
Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
![Scientists in the lab](/sites/default/files/2024-01/PR_Ribo.png)
January 03, 2024
Partnership for new liver disease treatments with Ribo
![Huebler_Schmelmer Huebler_Schmelmer](/sites/default/files/2023-12/Huebler_Schmelmer.jpg)
December 18, 2023
Boehringer Ingelheim announces appointments Board of Managing Directors
![Doctors in a discussion](/sites/default/files/2023-11/IBM%20PRess.jpg)
November 28, 2023
Partnership with IBM to accelerate new antibody therapies
![Diabetic cat with owner](/sites/default/files/2023-11/Diabetic%20cat%20with%20owner.png)
November 23, 2023
Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats
![Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss](/sites/default/files/2023-11/BI_Workplace_Lab_Discussion-01_RGB_001%20%281%29.jpg)
November 22, 2023
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
![Asi+empa image.jpg](/sites/default/files/2023-11/Asi%2Bempa%20image.jpg)
November 03, 2023
Boehringer Ingelheim achieves major milestone in chronic kidney disease
![Life forward release 1](/sites/default/files/2023-10/MicrosoftTeams-image%20%2810%29.png)
October 30, 2023
Life forward - Boehringer Ingelheim unveils its evolved company brand
![Prix Galien 2023.jpeg](/sites/default/files/2023-10/Prix%20Galien%202023.jpeg)
October 30, 2023
SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award
![Phase III trials_image.png](/sites/default/files/2023-10/Phase%20III%20trials_image.png)
October 05, 2023
Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease
![Woman and Man in Computer room](/sites/default/files/2023-10/AdobeStock_160945102.jpeg)
October 02, 2023
Partnership with Precision Health Research, Singapore
![Eye in detail](/sites/default/files/2023-10/CRD_PR.jpg)
October 02, 2023
Phase 1 start of treatment for Geographic Atrophy patients
October 02, 2023
Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss
![KMP_tree_ClimateSeed_Ⓒ Permian Global 1440 x 810 plus Copyright 460kb.jpg](/sites/default/files/2023-09/KMP_tree_ClimateSeed_%E2%92%B8%20Permian%20Global%201440%20x%20810%20plus%20Copyright%20460kb.jpg)
September 14, 2023
Boehringer Ingelheim receives SBTi validation for CO2 reduction targets
![Man with cattle herd](/sites/default/files/2023-08/Credits%20%40GALVmed%20Karel%20Prinsloo.jpg)
September 05, 2023
New partnership working on solutions to combat African animal trypanosomiasis
![Obesity release.png](/sites/default/files/2023-08/Obesity%20release.png)
August 17, 2023
Boehringer Ingelheim to advance survodutide into three global Phase III studies in obesity
![Man with cat on sofa](/sites/default/files/2023-08/FDA%20Approval%20Senvelgo.jpg)
August 14, 2023
Boehringer Ingelheim receives FDA approval for SENVELGO®: the first oral liquid medication for diabetes in cats
![HY 2023 press release image](/sites/default/files/2023-07/HY%202023%20press%20release%20image%20resized.jpg)
August 01, 2023
First half of 2023: strong growth and expansion in key therapy areas
July 28, 2023
FRONTLINE® wins Brand of the Year Award for the third time in a row
![Kidney Diseases Kidney Diseases](/sites/default/files/2023-07/hands%20%26%20kidney%20image_1280x720_v01%5B37%5D.jpg)
July 25, 2023
Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease
![Female veterinarian with dog in practise, woman and kid standing in background](/sites/default/files/2023-07/NexGard%20PLUS%2016x9.png)
July 20, 2023
Boehringer Ingelheim receives FDA approval for NexGard® PLUS: a beef-flavored soft chew that protects dogs from internal and external parasites
![A person touching a scientific data visualization](/sites/default/files/2023-07/MicrosoftTeams-image%20%286%29.png)
July 04, 2023
Spesolimab prevents GPP flares
![Scientist with tablet stock image](/sites/default/files/2023-06/Scientist%20with%20tablet.jpg)
June 23, 2023
Phase II trial data shows nearly 19% weight loss in people with overweight or obesity
![230622_CKD_CHMP_WebsiteCard_1440x810px.jpg](/sites/default/files/2023-06/230622_CKD_CHMP_WebsiteCard_1440x810px.jpg)
June 23, 2023
Jardiance® recommended for the treatment of adults with chronic kidney disease in the EU
![Phase II trial results in people living with obesity or overweight](/sites/default/files/2023-05/shutterstock_1901403778.jpg%201440%20%C3%97%20810.jpg)
May 10, 2023
Phase II trial results in people living with obesity or overweight
![colorful picture](/sites/default/files/2023-05/FibroticDisease.jpg)
May 09, 2023
IL-11 inhibitor antibody clinical development launched
![SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares Finger pointing at a digital tick box](/sites/default/files/2023-05/Spesolimab%20Breakthrough%20Designation%20Press%20Release%20Image.jpg)
May 02, 2023
Breakthrough Designation granted in US and China
![Dreyer_vonBaumbach_Scholz Dreyer_vonBaumbach_Scholz](/sites/default/files/2023-05/MicrosoftTeams-image%20%283%29.png)
May 02, 2023
Boehringer and German Chancellor Olaf Scholz lay the foundation stone for EUR 285 million innovation center
![Einweihung BDC](/sites/default/files/2023-04/Einweihung%20BDC%2024.April%20resized.png)
April 24, 2023
Boehringer inaugurates largest European development centre for biotechnology
![ARPC press release](/sites/default/files/2023-03/069_%C2%A9%202020%2C%20Peter%20Ginter%20-%20inspection%20shovel%20dryer%20fro%20website%20.jpg)
March 29, 2023
Boehringer Ingelheim reaches more patients than ever, innovation drives growth
![People standing in a circle in rural Africa](/sites/default/files/2023-02/LastMile%20Press%20Release%20Thumbnail.jpg)
March 02, 2023
LastMile initiative reaches over 40,000 smallholder farmers in Sub-Saharan Africa increasing access to veterinary medicine
![A doctor speaks to a patient about results of medical checks whilst sat in a general practice A female doctor speaks to a male patient about results of medical checks whilst sat in a general practice](/sites/default/files/2023-01/Effisayil%202%20-GettyImages-1212860058%20resize.jpg)
January 30, 2023
Spesolimab meets key endpoint for GPP flare prevention
![Empa_Kidney](/sites/default/files/2023-01/shutterstock__Klein.jpg)
January 24, 2023
FDA accepts application for new CKD treatment
![Top Employer 2023 Top Employer 2023](/sites/default/files/2023-01/BI_1570.jpg)
January 17, 2023
Global Top Employer 2023
![monecules](/sites/default/files/2023-01/Teaser_3t.jpg)
January 09, 2023
New cancer therapeutics collaboration with 3T Bio
![](/sites/default/files/Images/apc_2016_bic.jpg)
December 20, 2022
Boehringer Ingelheim announces appointments to Board of Managing Directors
![woman with mobilephone](/sites/default/files/2022-12/ClickTxTeaser.png)
December 19, 2022
New digital Tx collab with Click
![EC grants marketing authorization for spesolimab](/sites/default/files/2022-12/786212587-009_400x400px_cc01.jpg)
December 13, 2022
EC grants conditional marketing authorization for spesolimab
![New positive data in Phase III type 2 diabetes trial](/sites/default/files/2022-12/shutterstock_1021932094.jpg)
December 07, 2022
Phase III trial demonstrated Jardiance is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes
![EMPA-KIDNEY trial meets primary endpoint EMPA-KIDNEY trial meets primary endpoint](/sites/default/files/2022-11/BI%20Kidney%20image_1920x1080px_0.jpg)
November 04, 2022
Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease
![Tree shaped as lungs with the press release title On the left side of the image is the label which reads #Press’. Under the label is the text which reads First Patient enrolled in FIBRONEER-IPF Phase III trial. The right side of the image shows a tree shaped as lungs](/sites/default/files/2022-10/BI.com%20Post%20Release.jpg)
October 26, 2022
FIBRONEER™ Phase III program initiated in over 40 countries
![AI&Data Science Fellowship Tuebingen](/sites/default/files/2022-10/Tue%20Fellowship%20prog.jpg)
October 20, 2022
AI and Data Science Fellowship with University of Tuebingen
![Scientific laboratory staff member wearing a lab coat looks into a microscope Female scientific laboratory staff member wearing a lab coat uses a microscope by staring into it](/sites/default/files/2022-10/CHMP%20Upload%20form%20image_1440x810_CC02.jpg)
October 14, 2022
CHMP recommends conditional approval for first GPP treatment
![The 2022 PRRS Award Winners Collage of four individual headshots, three men, one woman](/sites/default/files/2022-09/PRRS%20Awards%202022%20Thumbnail%20%282%29.png)
October 10, 2022
Bridging science and veterinary practice for swine health: The winners of the European PRRS Award 2022
![Cowtribe in action](/sites/default/files/2022-09/20200823_112854.jpg)
October 05, 2022
Last-mile veterinary delivery social start-up Cowtribe first investment of Boehringer Ingelheim Social Engagements
![Birth of a calf](/sites/default/files/2022-09/335A4008.jpg)
September 06, 2022
Boehringer Ingelheim launches Fencovis®, a new vaccine to prevent calf diarrhea
![New Phase III data in children living with ILD New Phase III data in children living with ILD](/sites/default/files/2022-09/InPedILD_ERS_press_release.jpg)
September 05, 2022
New data for nintedanib in children with fibrosing interstitial lung disease
![Person holds scientific breakthrough in their hands Businessman using digital x-ray human body scan interface 3D rendering](/sites/default/files/2022-09/Image-for-FDA-Press-release_1440x810px.jpg)
September 02, 2022
First approval for SPEVIGO® to treat GPP flares
![People working in a lab](/sites/default/files/2022-08/16%209%20size%20People%20working%20in%20a%20lab.jpg)
August 03, 2022